Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Harbarth

Showing results (401-410 of 420) with videos related to

Pageof 42
Sort By:
The Journal of Antimicrobial Chemotherapy|January 21, 2014
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care unitsGloria Wong, Alexander Brinkman, Russell J Benefield, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patientsMaria E Riccio, Tess Verschuuren, Nadine Conzelmann, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 8, 2022
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseasesNasreen Hassoun-Kheir, C Henri van Werkhoven, Jake Dunning, et al.
Infection Control and Hospital Epidemiology|March 26, 2026
Implementation of an adaptable semi-automated nonventilator hospital-acquired pneumonia (nvHAP) surveillance system in swiss acute care hospitals: a feasibility studyAline Wolfensberger, Mirjam Faes Hesse, Marc Hany, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 27, 2016
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort studyAndrew J Stewardson, Arthur Allignol, Jan Beyersmann, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2024
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control studyHongyu Zhou, Niccolò Buetti, Salvador Pérez-Galera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2024
Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodiesNasreen Hassoun-Kheir, Mariana Guedes, Fabiana Arieti, et al.
Lancet (London, England)|February 12, 2023
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationChristine Årdal, Enrico Baraldi, Reinhard Busse, et al.
The Lancet. Infectious Diseases|August 28, 2020
Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistanceDidier Wernli, Peter S Jørgensen, E Jane Parmley, et al.
Pageof 42

Showing results (401-410 of 420) with videos related to

Sort By:
Pageof 42
The Journal of Antimicrobial Chemotherapy|January 21, 2014
An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care unitsGloria Wong, Alexander Brinkman, Russell J Benefield, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 9, 2021
Household acquisition and transmission of extended-spectrum β-lactamase (ESBL) -producing Enterobacteriaceae after hospital discharge of ESBL-positive index patientsMaria E Riccio, Tess Verschuuren, Nadine Conzelmann, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 8, 2022
Perpetual observational studies: new strategies to support efficient implementation of observational studies and randomized trials in infectious diseasesNasreen Hassoun-Kheir, C Henri van Werkhoven, Jake Dunning, et al.
Infection Control and Hospital Epidemiology|March 26, 2026
Implementation of an adaptable semi-automated nonventilator hospital-acquired pneumonia (nvHAP) surveillance system in swiss acute care hospitals: a feasibility studyAline Wolfensberger, Mirjam Faes Hesse, Marc Hany, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|August 27, 2016
The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort studyAndrew J Stewardson, Arthur Allignol, Jan Beyersmann, et al.
The Lancet. Infectious Diseases|February 28, 2017
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trialAngela Huttner, Christoph Hatz, Germie van den Dobbelsteen, et al.
The Journal of Antimicrobial Chemotherapy|July 11, 2024
Risk factors for bloodstream infections due to carbapenem-resistant Enterobacterales: a nested case-control-control studyHongyu Zhou, Niccolò Buetti, Salvador Pérez-Galera, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 22, 2024
Expert consensus on antimicrobial resistance research priorities to focus development and implementation of antibacterial vaccines and monoclonal antibodiesNasreen Hassoun-Kheir, Mariana Guedes, Fabiana Arieti, et al.
Lancet (London, England)|February 12, 2023
Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovationChristine Årdal, Enrico Baraldi, Reinhard Busse, et al.
The Lancet. Infectious Diseases|August 28, 2020
Evidence for action: a One Health learning platform on interventions to tackle antimicrobial resistanceDidier Wernli, Peter S Jørgensen, E Jane Parmley, et al.
Pageof 42